ALGN Align Technology
FY2024 10-K
Align Technology (ALGN) filed its fiscal year 2024 10-K annual report with the SEC on Feb 28, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Business Overview
- • Core business model: global medical device firm revolutionizing orthodontics and restorative dentistry via the integrated Align™ Digital Platform (Invisalign clear aligners, iTero scanners, exocad software)
- • New product launches in 2024: iTero Lumina™ intraoral scanner, iTero Multi-Direct Capture™ technology, ClinCheck® Smile Video, Invisalign Palatal Expander System with FDA 510(k) clearance
Management Discussion & Analysis
- • Revenue not explicitly stated; 2024 sales adversely impacted by macroeconomic conditions and strong U.S. dollar
- • No specific profitability or margin figures disclosed in MD&A section provided
Risk Factors
- • Foreign currency risk with exposure to Euro, British Pound, Chinese Yuan, Polish Zloty, Canadian Dollar; 10% rate change could materially impact results
- • Inflation risk from rising global costs may outpace price increases, potentially harming revenues and operating results
Financial SummaryXBRL
Revenue
$4.0B
Net Income
$421M
Gross Margin
70.0%
Operating Margin
15.2%
Net Margin
10.5%
ROE
10.9%
Total Assets
$6.2B
EPS (Diluted)
$5.62
Operating Cash Flow
$738M
Source: XBRL data from Align Technology FY2024 10-K filing on SEC EDGAR. All figures in USD.
Other Align Technology Annual Reports
Get deeper insights on Align Technology
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.